Global CRO brings patient-derived models, organoid platforms and biomarker expertise to collaborative effort advancing regulatory acceptance of New Approach Methodologies SAN DIEGO–BUSINESS WIRE– Crown Bioscience is a global contract research organization (CRO) specializing in oncology drug discovery and development, today announced it has joined Critical Path Institute’s (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC), a ... Continued